Your browser doesn't support javascript.
loading
Value of PET imaging for radiation therapy.
Lapa, Constantin; Nestle, Ursula; Albert, Nathalie L; Baues, Christian; Beer, Ambros; Buck, Andreas; Budach, Volker; Bütof, Rebecca; Combs, Stephanie E; Derlin, Thorsten; Eiber, Matthias; Fendler, Wolfgang P; Furth, Christian; Gani, Cihan; Gkika, Eleni; Grosu, Anca-L; Henkenberens, Christoph; Ilhan, Harun; Löck, Steffen; Marnitz-Schulze, Simone; Miederer, Matthias; Mix, Michael; Nicolay, Nils H; Niyazi, Maximilian; Pöttgen, Christoph; Rödel, Claus M; Schatka, Imke; Schwarzenboeck, Sarah M; Todica, Andrei S; Weber, Wolfgang; Wegen, Simone; Wiegel, Thomas; Zamboglou, Constantinos; Zips, Daniel; Zöphel, Klaus; Zschaeck, Sebastian; Thorwarth, Daniela; Troost, Esther G C.
Affiliation
  • Lapa C; Nuclear Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany.
  • Nestle U; Department of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
  • Albert NL; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
  • Baues C; Department of Radiation Oncology, Kliniken Maria Hilf, Mönchengladbach, Germany.
  • Beer A; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Buck A; Department of Radiation Oncology, Cyberknife and Radiotherapy, Medical Faculty, University Hospital Cologne, Cologne, Germany.
  • Budach V; Department of Nuclear Medicine, Ulm University Hospital, Ulm, Germany.
  • Bütof R; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
  • Combs SE; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany.
  • Derlin T; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Eiber M; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
  • Fendler WP; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Furth C; Department of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
  • Gani C; Department of Radiation Sciences (DRS), Institute of Radiation Medicine (IRM), Neuherberg, Germany.
  • Gkika E; Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
  • Grosu AL; Department of Nuclear Medicine, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany.
  • Henkenberens C; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
  • Ilhan H; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Löck S; German Cancer Consortium (DKTK), Partner Site Tübingen, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Marnitz-Schulze S; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
  • Miederer M; Department of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
  • Mix M; Department of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
  • Nicolay NH; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
  • Niyazi M; Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany.
  • Pöttgen C; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Rödel CM; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Schatka I; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
  • Schwarzenboeck SM; Department of Radiation Oncology, Cyberknife and Radiotherapy, Medical Faculty, University Hospital Cologne, Cologne, Germany.
  • Todica AS; Department of Nuclear Medicine, University Hospital Mainz, Mainz, Germany.
  • Weber W; Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Wegen S; Department of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
  • Wiegel T; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.
  • Zamboglou C; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Zips D; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Zöphel K; Department of Radiation Oncology, West German Cancer Centre, University of Duisburg-Essen, Essen, Germany.
  • Zschaeck S; German Cancer Consortium (DKTK), Partner Site Frankfurt, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Thorwarth D; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.
  • Troost EGC; Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Strahlenther Onkol ; 197(9): 1-23, 2021 09.
Article in En | MEDLINE | ID: mdl-34259912
ABSTRACT
This comprehensive review written by experts in their field gives an overview on the current status of incorporating positron emission tomography (PET) into radiation treatment planning. Moreover, it highlights ongoing studies for treatment individualisation and per-treatment tumour response monitoring for various primary tumours. Novel tracers and image analysis methods are discussed. The authors believe this contribution to be of crucial value for experts in the field as well as for policy makers deciding on the reimbursement of this powerful imaging modality.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Positron-Emission Tomography / Neoplasms Limits: Humans Language: En Journal: Strahlenther Onkol Journal subject: NEOPLASIAS / RADIOTERAPIA Year: 2021 Document type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Positron-Emission Tomography / Neoplasms Limits: Humans Language: En Journal: Strahlenther Onkol Journal subject: NEOPLASIAS / RADIOTERAPIA Year: 2021 Document type: Article Affiliation country: Germany